Healthcare Investing: Finding Growth Beyond Pharmaceuticals

AllianceBernstein

Research

10 Pages

AllianceBernstein argues healthcare investors should look beyond large pharmaceutical stocks to capture the sector’s broader growth potential. The article shows pharma’s MSCI World Health Care weight has fallen from 82% in 2000 to 45% today, while sector leadership changes frequently.

Key Takeaways

Pharma dominance fell: Pharma stocks fell from 82% of MSCI World Health Care in 2000 to 45% today, still dominating index exposure.
Drug risk persists: Less than 10% of drugs entering clinical trials receive FDA approval, making concentrated pharma exposure inherently binary.
Leadership rotates: Pharmaceuticals led healthcare only once in the past decade, while equipment and life-science tools often led returns.

Join our newsletter to have all of this content + Exclusive Newsletter Bonus Content delivered to your inbox every week

Related Content

Scroll to Top